Australia's most trusted
source of pharma news
Friday, 27 February 2026
Friday, 27 February 2026
Subscribe
Login
Sales are booming for these drugs
Top line Federal Government spending on the R/PBS increasing by a tenth over 2025, but much of that growth was snaffled by just a few drugs. See which 10 medicines are the scheme's fastest growers.
Rookie outshines blockbuster
This newcomer has shown superiority to one of the world's biggest drugs, adding another competitor to an already hot market
TODAY
Call for action on rare disease
Organisations across Asia Pacific have joined MSD in calling for action on a rare disease that affects thousands of Australians
TODAY
Global piles on pressure for growth
How ANZ leaders can meet growth expected by boards, global leadership and shareholders despite squeezed budgets
26 February
Oncologists rank favourite pharmas
Perception survey reveals HCPs in oncology favour pharmas with a broad portfolio of drugs rather than a single blockbuster
25 February
TGA targets pharma for millions
The regulator believes the pharma industry owes it tens of millions of dollars, and it's looking at ways to collect
25 February
2026 burnout takes hold... already
Just seven weeks into the year and pharma employees are already buckling under the strain of working multiple roles and long hours
24 February
Latest Jobs
Materials PlannerCustomer Service RepresentativeSenior Manager, Clinical Operations (Japan)Senior Manager, Regulatory Affairs OperationsSenior Clinical Project ManagerAssociate Director Regulatory Operations (Japan)Regulatory & Quality ManagerProcurement Specialist30 more...
Pharma in Focus Jobs
Marketing & Communications (2)
Sales & Customer Relations (11)
- Customer Service Representative - Pemulwuy
- Customer Service Representative - St Leonards
- Customer Service Specialist - Frenchs Forest
- Pharmaceutical Sales Representative - Brisbane
- Customer Service Representative - St Leonards
- Territory Manager - Capital Equipment - Melbourne
- Junior Accountant - Sydney
- Territory Manager - Melbourne
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Customer Service Representative - St Leonards
- Hospital Sales Representative - Melbourne
Clinical & Medical, R&D (6)
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Senior Clinical Project Manager - Tokyo, Japan
- Quality & Medical Operations Specialist - Sydney
- Medical Advisor - Sydney
- Head of Medical - Sydney
- Associate Business Development Director - Clinical Research, China - Shanghai, China
Regulatory, Pharmacovigilance & QA (5)
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Regulatory & Quality Manager - Melbourne
- Senior Quality Associate - New South Wales
- Quality & Medical Operations Specialist - Sydney
Executive Roles (4)
- Senior Manager, Clinical Operations (Japan) - Tokyo, Japan
- Senior Manager, Regulatory Affairs Operations - Tokyo, Japan
- Associate Director Regulatory Operations (Japan) - Tokyo, Japan
- Associate Business Development Director - Clinical Research, China - Shanghai, China
Other (17)
- Materials Planner - North Ryde
- Procurement Specialist - New South Wales
- Finance & Administration Officer - Macquarie Park
- Re-manufacturing Operator - New South Wales
- Warehouse Assistant - Blacktown
- Pharmacy Assistant - Toongabbie
- QC Analyst -Biochemistry - Melbourne
- SAP Project Lead - Brisbane
- Logistics Manager - Sydney
- Finance Manager - Melbourne
- Senior Recruitment Consultant - Victoria
- Distribution and Warehouse Technician - Broadmeadows
- Recruitment Consultant - Sydney
- Warehouse Associate - Chatswood
- Logistics Specialist - Macquarie Park
- Chief Operating Officer - Sydney
- Chief Operating Officer - Sydney
Aussie leader wins global award
Recognised with the highest honour for not only delivering excellence but for building community, elevating others, and driving impact
26 February
Aussie market next for pain drug
Non-opioid pain patch marketed in the US and Europe headed Down Under following new licensing agreement
26 February
Aussie execs landing new roles
New hires, big promotions plus a well-known leader launches an advisory firm in the latest employment moves across pharma
26 February
Hyped drug fails to reach Aust
Company voluntarily pulls drug accepted for TGA review in 2023, from all markets after an uphill commercialisation battle
26 February
Putting patients before business
Global pharma employees paused their daily schedule to contemplate the company's values in decision-making
25 February
Aussie 1st-to-market race heats up
Another 'No' for reimbursement tightens the race to launch the first oral SERD in Australia, with three companies in the running
25 February
Gilead inks US$7.8B buyout
Setting up a red-hot rivalry with Johnson & Johnson and BMS in a hard-fought therapy space and it's ready to move 'with speed'
25 February
Novo's big hope fails against Lilly
Much hyped combo for obesity found to be less effective than Lilly's obesity blockbuster, sending the share price tumbling
24 February
Arrotex inks fresh licensing deal
Company forges path into the innovative medicines space announcing an exclusive licensing deal with a Taiwan-based pharma
24 February
Global pharma eyes Aussie drug
Clinical collaboration to trial a combination treatment in Australia for late-stage cancers set to commence later this year
24 February
AusDoc broadens audience
New national strategic partnership aimed at strengthening the primary care ecosystem by targeting these essential healthcare workers
24 February
Fallen blockbusters shake up PBS
Loss of exclusivity saw a shake-up in the highest PBS earners list in 2025, although one giant drug has beaten off generic competition
23 February
Aussie company sells for $1.6B
After making its mark selling compounded semaglutide via telehealth, this company has been snapped up by a US giant
23 February
Pharma future looking up? Maybe
While there's been an upturn in sentiment it's nowhere near enough to quash overwhelming concern about the current state of industry
23 February